Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

BECKMAN COULTER, INC.

Beckman Coulter develops, manufactures and markets laboratory systems, reagents, centrifugation, lab automation, elec... read more Featured Products: More products

Download Mobile App




Urinary NAG-Creatine Ratio Predicts Advanced Diabetic Kidney Disease

By LabMedica International staff writers
Posted on 03 Jan 2023

Diabetes is the leading cause of chronic kidney disease and end-stage kidney disease worldwide and becomes one of the biggest healthcare challenges of the 21st century. Microvascular complications have been identified as the common and major diabetic complications.

Diabetic Kidney Disease (DKD) typically manifests a progressive deterioration of kidney function, and the increased glomerular filtration rate (GFR), glomerular hypertrophy, and excretion of urinary albumin are the major indicators. Various urine proteins may exhibit significant differences in diagnostic, predictive, and prognostic power for DKD.

Medical Scientists at the Suzhou Medical College of Soochow University (Suzhou, China) retrospectively analyzed a total of 117 patients with type 2 DKD, 83 males and 34 females, aged 37–85 years, including early and advanced stages and their laboratory parameters were statistically assessed. The patients were divided into two groups: early (stages IIa and IIb) and advanced (stages III and IV) groups based on the pathological grading.

The urine in spot time and whole 24 hours was obtained, and the fasting venous blood of patients were collected in vacutainer tubes. A BC-7500 automatic hematological analyzer (Mindray Inc, Shenzhen, China) was used to analyze the white blood cell (WBC), neutrophil (NEU), and high sensitive C reactive protein (HS-CRP). Multiple biochemical indexes were measured, which included serum creatine (sCR), serum urea (sUR), cholesterol (CHOL), homocysteine (HCY), thyroid stimulating hormone (TSH), free triiodothyronine (FT3), free thyroxine (FT4), fibrinogen (FIB), and d-dimer (D-D).

The levels of urinary creatinine, N-acetyl-β-d-glucosaminidase (NAG), total protein (PRO), microalbumin (MA), immunoglobulin G (IgG), transferrin (TFR), and α1-microglobulin (α1MG) in spot urine, and albumin excretion (UAE) in 24 hour urine were measured by the AU5800 fully automated biochemical analyzer (Beckman-Coulter, Brea, CA, USA). Urinary N-acetyl-β-d-glucosaminidase (NAG) and proteins to creatinine ratios were calculated to present as NAG/CR, PRO/CR, albumin to creatine ratio (ACR), IgG/CR, TFR/CR, and α1MG/CR.

The investigators reported that N-acetyl-β-d-glucosaminidase-creatine (NAG/CR) level in advanced DKD was statistically higher than that in early DKD, and there was a higher incidence of advanced DKD (72% versus 56%) and high odds ratio (OR: 3.917) of NAG/CR with ≥2.79 U/mmol compared with <2.79 U/mmol. NAG/CR ratio also showed a higher area under the ROC curve of 0.727 with a high sensitivity (0.75) and a moderate specificity (0.66) when 1.93 U/mmol was set as the optimal cutoff value. The adjusted-multivariable analysis revealed that NAG/CR had an OR of 1.021 and 2.223 based on a continuous and categorical variable, respectively, for risk of advanced DKD. Moreover, the prevalence of advanced DKD exhibited an increasing tendency by an increment of the trisector of NAG/CR.

The authors concluded that NAG/CR ratio is an independent predictor for advanced DKD in type 2 diabetes (T2D) patients, and it also can be used as a powerful identifying marker between early and advanced DKD. The study was published on December 26, 2022 in the Journal of Clinical Laboratory Analysis.


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Liquid Ready-To-Use Lp(a) Reagent
Lipoprotein (a) Reagent
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.